FBXO30: A Protein Involved in F-box Domain Protein Interaction and Cellular Processes

Target Name: FBXO30

NCBI ID: G84085

FBXO30

FBXO30: A Protein Involved in F-box Domain Protein Interaction and Cellular Processes

The F-box domain is a protein-coding region that is found in a variety of organisms, including humans. It is characterized by a specific pattern of amino acid sequence, which is composed of a long conserved core region that is flanked by a short, variable region. The F-box domain is known for its ability to form a stable complex with various protein partners, including other proteins known as co-factors.

One of the functions of the F-box domain is to act as a protein-protein interaction (PPI) site. This involves the formation of a covalent complex between the F-box domain and a partner protein, which can then influence the activity, stability, or function of the partner protein. The F-box domain is often involved in the regulation of a wide range of cellular processes, including cell growth, differentiation, and metabolism.

One of the FBXO30 protein is a protein that is known as the F-box domain protein (FBP). FBXO30 is a member of the F-box protein family and is found in various organisms, including humans. It is characterized by a long conserved F-box domain that is responsible for its protein-protein interaction abilities.

The F-box domain is a critical region of the protein that is involved in the regulation of various cellular processes. It is known to play a role in the regulation of cell growth, differentiation, and metabolism. FBXO30 is a protein that is known to be involved in these processes, and it is thought to be a potential drug target or biomarker.

FBXO30 is a protein that is expressed in various tissues of the body, including the brain, muscle, and blood. It is also known to be involved in the regulation of cellular processes that are important for brain development and function. FBXO30 is thought to be involved in the regulation of the neurotransmitter systems, which are responsible for transmitting signals in the brain.

FBXO30 is also known to be involved in the regulation of cellular processes that are important for muscle development and function. It is thought to be involved in the regulation of the myogenic transition, which is the process by which muscle cells differentiate into functional muscles. FBXO30 is also known to be involved in the regulation of muscle protein synthesis and degradation, which are important for muscle growth and maintenance.

FBXO30 is also thought to be involved in the regulation of cellular processes that are important for blood development and function. It is known to be involved in the regulation of hemoglobin synthesis, which is the process by which red blood cells are produced in the bone marrow. FBXO30 is also thought to be involved in the regulation of integrin function, which is the process by which cells stick to each other in various tissues.

In conclusion, the F-box domain protein (FBP) is a protein that is characterized by a long conserved F-box domain that is involved in protein-protein interaction. FBXO30 is a member of the F-box protein family and is found in various organisms, including humans. It is thought to be involved in the regulation of various cellular processes, including cell growth, differentiation, and metabolism. FBXO30 is also thought to be involved in the regulation of neurotransmitter systems, muscle development and function, and blood development and function. Therefore, it is a potential drug target or biomarker.

Protein Name: F-box Protein 30

Functions: Substrate-recognition component of the SCF (SKP1-CUL1-F-box protein)-type E3 ubiquitin ligase complex. Required for muscle atrophy following denervation

The "FBXO30 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about FBXO30 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets